Summary

The global Carvedilol market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Carvedilol (CAS 72956-09-3), C24H26N2O4, the formula weight is 406.47, and its form is white to off-white solid.
Carvedilol is indicated for symptomatic heart failure and for essential hypertension.
LP Information, Inc. (LPI) ' newest research report, the “Carvedilol Industry Forecast” looks at past sales and reviews total world Carvedilol sales in 2024, providing a comprehensive analysis by region and market sector of projected Carvedilol sales for 2025 through 2031. With Carvedilol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carvedilol industry.
This Insight Report provides a comprehensive analysis of the global Carvedilol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Carvedilol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Carvedilol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carvedilol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carvedilol.
This report presents a comprehensive overview, market shares, and growth opportunities of Carvedilol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Capsule
Segmentation by Application:
Primary Hypertension
Congestive Heart Failure (CHF)
Left Ventricular Dysfunction
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Qilu Pharmaceutical
Roche
Cipla
Ningbo Tianheng Pharmaceutical
Apotex INC
Aurobindo Pharma
BEXIMCO USA
Teva
Mylan
TARO
Sun Pharminds
Zydus Pharms
Lupin
Sandoz
Glenmark Generics
DR Reddy's Labs
Chartwell Molecular
Key Questions Addressed in this Report
What is the 10-year outlook for the global Carvedilol market?
What factors are driving Carvedilol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Carvedilol market opportunities vary by end market size?
How does Carvedilol break out by Type, by Application?

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Carvedilol Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Carvedilol by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Carvedilol by Country/Region, 2020, 2024 & 2031
2.2 Carvedilol Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.3 Carvedilol Sales by Type
2.3.1 Global Carvedilol Sales Market Share by Type (2020-2025)
2.3.2 Global Carvedilol Revenue and Market Share by Type (2020-2025)
2.3.3 Global Carvedilol Sale Price by Type (2020-2025)
2.4 Carvedilol Segment by Application
2.4.1 Primary Hypertension
2.4.2 Congestive Heart Failure (CHF)
2.4.3 Left Ventricular Dysfunction
2.4.4 Other
2.5 Carvedilol Sales by Application
2.5.1 Global Carvedilol Sale Market Share by Application (2020-2025)
2.5.2 Global Carvedilol Revenue and Market Share by Application (2020-2025)
2.5.3 Global Carvedilol Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Carvedilol Breakdown Data by Company
3.1.1 Global Carvedilol Annual Sales by Company (2020-2025)
3.1.2 Global Carvedilol Sales Market Share by Company (2020-2025)
3.2 Global Carvedilol Annual Revenue by Company (2020-2025)
3.2.1 Global Carvedilol Revenue by Company (2020-2025)
3.2.2 Global Carvedilol Revenue Market Share by Company (2020-2025)
3.3 Global Carvedilol Sale Price by Company
3.4 Key Manufacturers Carvedilol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Carvedilol Product Location Distribution
3.4.2 Players Carvedilol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Carvedilol by Geographic Region
4.1 World Historic Carvedilol Market Size by Geographic Region (2020-2025)
4.1.1 Global Carvedilol Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Carvedilol Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Carvedilol Market Size by Country/Region (2020-2025)
4.2.1 Global Carvedilol Annual Sales by Country/Region (2020-2025)
4.2.2 Global Carvedilol Annual Revenue by Country/Region (2020-2025)
4.3 Americas Carvedilol Sales Growth
4.4 APAC Carvedilol Sales Growth
4.5 Europe Carvedilol Sales Growth
4.6 Middle East & Africa Carvedilol Sales Growth
5 Americas
5.1 Americas Carvedilol Sales by Country
5.1.1 Americas Carvedilol Sales by Country (2020-2025)
5.1.2 Americas Carvedilol Revenue by Country (2020-2025)
5.2 Americas Carvedilol Sales by Type (2020-2025)
5.3 Americas Carvedilol Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carvedilol Sales by Region
6.1.1 APAC Carvedilol Sales by Region (2020-2025)
6.1.2 APAC Carvedilol Revenue by Region (2020-2025)
6.2 APAC Carvedilol Sales by Type (2020-2025)
6.3 APAC Carvedilol Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Carvedilol by Country
7.1.1 Europe Carvedilol Sales by Country (2020-2025)
7.1.2 Europe Carvedilol Revenue by Country (2020-2025)
7.2 Europe Carvedilol Sales by Type (2020-2025)
7.3 Europe Carvedilol Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Carvedilol by Country
8.1.1 Middle East & Africa Carvedilol Sales by Country (2020-2025)
8.1.2 Middle East & Africa Carvedilol Revenue by Country (2020-2025)
8.2 Middle East & Africa Carvedilol Sales by Type (2020-2025)
8.3 Middle East & Africa Carvedilol Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Carvedilol
10.3 Manufacturing Process Analysis of Carvedilol
10.4 Industry Chain Structure of Carvedilol
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Carvedilol Distributors
11.3 Carvedilol Customer
12 World Forecast Review for Carvedilol by Geographic Region
12.1 Global Carvedilol Market Size Forecast by Region
12.1.1 Global Carvedilol Forecast by Region (2026-2031)
12.1.2 Global Carvedilol Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Carvedilol Forecast by Type (2026-2031)
12.7 Global Carvedilol Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Qilu Pharmaceutical
13.1.1 Qilu Pharmaceutical Company Information
13.1.2 Qilu Pharmaceutical Carvedilol Product Portfolios and Specifications
13.1.3 Qilu Pharmaceutical Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Qilu Pharmaceutical Main Business Overview
13.1.5 Qilu Pharmaceutical Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Carvedilol Product Portfolios and Specifications
13.2.3 Roche Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Cipla
13.3.1 Cipla Company Information
13.3.2 Cipla Carvedilol Product Portfolios and Specifications
13.3.3 Cipla Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cipla Main Business Overview
13.3.5 Cipla Latest Developments
13.4 Ningbo Tianheng Pharmaceutical
13.4.1 Ningbo Tianheng Pharmaceutical Company Information
13.4.2 Ningbo Tianheng Pharmaceutical Carvedilol Product Portfolios and Specifications
13.4.3 Ningbo Tianheng Pharmaceutical Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ningbo Tianheng Pharmaceutical Main Business Overview
13.4.5 Ningbo Tianheng Pharmaceutical Latest Developments
13.5 Apotex INC
13.5.1 Apotex INC Company Information
13.5.2 Apotex INC Carvedilol Product Portfolios and Specifications
13.5.3 Apotex INC Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Apotex INC Main Business Overview
13.5.5 Apotex INC Latest Developments
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Information
13.6.2 Aurobindo Pharma Carvedilol Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Aurobindo Pharma Main Business Overview
13.6.5 Aurobindo Pharma Latest Developments
13.7 BEXIMCO USA
13.7.1 BEXIMCO USA Company Information
13.7.2 BEXIMCO USA Carvedilol Product Portfolios and Specifications
13.7.3 BEXIMCO USA Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BEXIMCO USA Main Business Overview
13.7.5 BEXIMCO USA Latest Developments
13.8 Teva
13.8.1 Teva Company Information
13.8.2 Teva Carvedilol Product Portfolios and Specifications
13.8.3 Teva Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Teva Main Business Overview
13.8.5 Teva Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Carvedilol Product Portfolios and Specifications
13.9.3 Mylan Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 TARO
13.10.1 TARO Company Information
13.10.2 TARO Carvedilol Product Portfolios and Specifications
13.10.3 TARO Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 TARO Main Business Overview
13.10.5 TARO Latest Developments
13.11 Sun Pharminds
13.11.1 Sun Pharminds Company Information
13.11.2 Sun Pharminds Carvedilol Product Portfolios and Specifications
13.11.3 Sun Pharminds Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sun Pharminds Main Business Overview
13.11.5 Sun Pharminds Latest Developments
13.12 Zydus Pharms
13.12.1 Zydus Pharms Company Information
13.12.2 Zydus Pharms Carvedilol Product Portfolios and Specifications
13.12.3 Zydus Pharms Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zydus Pharms Main Business Overview
13.12.5 Zydus Pharms Latest Developments
13.13 Lupin
13.13.1 Lupin Company Information
13.13.2 Lupin Carvedilol Product Portfolios and Specifications
13.13.3 Lupin Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Lupin Main Business Overview
13.13.5 Lupin Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Carvedilol Product Portfolios and Specifications
13.14.3 Sandoz Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Glenmark Generics
13.15.1 Glenmark Generics Company Information
13.15.2 Glenmark Generics Carvedilol Product Portfolios and Specifications
13.15.3 Glenmark Generics Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Glenmark Generics Main Business Overview
13.15.5 Glenmark Generics Latest Developments
13.16 DR Reddy's Labs
13.16.1 DR Reddy's Labs Company Information
13.16.2 DR Reddy's Labs Carvedilol Product Portfolios and Specifications
13.16.3 DR Reddy's Labs Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 DR Reddy's Labs Main Business Overview
13.16.5 DR Reddy's Labs Latest Developments
13.17 Chartwell Molecular
13.17.1 Chartwell Molecular Company Information
13.17.2 Chartwell Molecular Carvedilol Product Portfolios and Specifications
13.17.3 Chartwell Molecular Carvedilol Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Chartwell Molecular Main Business Overview
13.17.5 Chartwell Molecular Latest Developments
14 Research Findings and Conclusion